retatrutide reviews and complaints Retatrutide, an experimental weight-loss drug, has not been approved by the FDA. But, doctors nurse practitioners in clinics across the country are prescribing it anyway, a CBS News investigation Retatrutide vs Tirzepatide (2026): Differences

Ziltzer and our clinical team provide the expert monitoring you deserve

Your monthly program fee includes the medication itself, required lab work review, a comprehensive health assessment, and ongoing clinical check-ins where your dosage and plan are adjusted to your progress

The effect is powerful and immediate, which is both its greatest strength and its fundamental limitation

Appetite suppression: the first signal Appetite reduction is typically the first noticeable effect

For patients with persistent reflux symptoms despite 8 weeks of PPI therapy or those with alarm features, referral to gastroenterology for upper endoscopy may be warranted, consistent with American College of Gastroenterology guidelines